The Lynx Group

American Society of Gene and Cell Therapy

Poliovirus Shows Complete Response in Several Glioblastoma Patients

In a role reversal, poliovirus is fast becoming a viable therapy for one of cancer’s deadliest diseases. Researchers at The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center are using engineered poliovirus to treat recurrent glioblastoma—making tumors disappear and extending survival beyond 3 years in some patients. [ Read More ]

Intralesional Oncolytic Immunotherapies Show Benefit in Melanoma

For patients with advanced melanoma, checkpoint inhibitors are not the only means of modulating the immune system to treat disease. According to research presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, intralesional oncolytic therapy is also providing profound benefit in several phase 2 and phase [ Read More ]

Sign me up!